Importer of Controlled Substances Application: Mylan Technologies, Inc., 65609-65610 [2022-23613]
Download as PDF
<![CDATA[
65609
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1068]
Importer of Controlled Substances
Application: Curia New York, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curia New York, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
SUMMARY:
on or before November 30, 2022. Such
persons may also file a written request
for a hearing on the application on or
before November 30, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 18, 2022, Curia
New York, Inc., 33 Riverside Avenue,
Rensselaer, New York 12144–2951,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
ANPP (4-Anilino-N-phenethyl-4-piperidine) ...........................................................................................................................
Poppy Straw Concentrate .....................................................................................................................................................
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for distribution to its customers. No
other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–23612 Filed 10–28–22; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1108]
khammond on DSKJM1Z7X2PROD with NOTICES
Importer of Controlled Substances
Application: Mylan Technologies, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Mylan Technologies, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
SUMMARY:
VerDate Sep<11>2014
17:15 Oct 28, 2022
Jkt 259001
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 30, 2022. Such
persons may also file a written request
for a hearing on the application on or
before November 30, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Schedule
8333
9670
II
II
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on October 4, 2022, Mylan
Technologies, Inc., 110 Lake Street,
Saint Albans, Vermont 05478–2266,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
Drug
code
Controlled substance
Methylphenidate ...........
Fentanyl ........................
I
1724
9801
Schedule
I
II
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically manufactured FDF. This
analysis is required to allow the
company to export domestically
manufactured FDF to foreign markets.
No other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
E:\FR\FM\31OCN1.SGM
31OCN1
65610
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–23613 Filed 10–28–22; 8:45 am]
BILLING CODE P
Overview of This Information
Collection
DEPARTMENT OF JUSTICE
[OMB Number 1121–XXXX]
Agency Information Collection
Activities; Proposed eCollection;
eComments Requested; Existing
Collection in Use Without an OMB
Control Number: AVUE Digital
Services—Electronic Applications
Office of Justice Programs,
Department of Justice.
ACTION: 30 Day notice.
AGENCY:
The Office of Justice
Programs, Department of Justice (DOJ),
will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: The Department of Justice
encourages public comment and will
accept input until November 30, 2022.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Office of Justice
Progrms, including whether the
information will have practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
17:15 Oct 28, 2022
Jkt 259001
1. Type of Information Collection:
Existing collection in use without an
OMB Control Number.
2. The Title of the Form/Collection:
The Avue Digital Services application
for federal employment.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
NA.
Sponsor: The Office of Justice
Programs, Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: The primary respondents are
public citizens who are applying for OJP
federal positions. Avue is a web-based
application system that provides
automated support for posting federal
vacancies. The applicants use the
system to submit electronic applications
for job vacancies. Candidates enter
pertinent information and responds to a
series of electronic screens and
experience statements. The data is then
certified and submitted for OJP HR
Specialists to review and certify the
applications. The candidate is
automatically notified by email that his/
her application has been received when
he/she certifies and submits his/her
electronic application and provided
other status updates throughout the
hiring cycle.
5. An Estimate of the Total Number of
Respondents and the Amount of Time
Estimated for an Average Respondent to
Respond: In calendar year 2021, there
were 1,707 applications submitted for
jobs at OJP. A sampling of applicants
who started and completed their OJP
applications on the same day in 2021
was 740 applicants and using this
sample, the system reported a total of
56,832 minutes for those 740
applications, or an average of 76.8
minutes (76 minutes, 48 seconds) spent
on each application.
6. An Estimate of the Total Public
Burden (in hours) Associated with the
collection: The estimated public burden
associated with this application is 949
hours in calendar year 2021. This is
based on 740 applicants spending 77
(rounded up) minutes on each
application for a total of 56,980 minutes.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
If additional information is required
contact: Robert Houser, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
United States Department of Justice,
Two Constitution Square, 145 N Street
NE, Suite 3E.206, Washington, DC
20530.
Dated: October 25, 2022
Robert Houser,
Department Clearance Officer, Policy and
Planning Staff, Office of the Chief Information
Officer, U.S. Department of Justice.
[FR Doc. 2022–23592 Filed 10–28–22; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act
On October 24, 2022, the Department
of Justice lodged a proposed Consent
Decree with the United States District
Court for the Northern District of
Indiana in the lawsuit entitled United
States and State of Indiana v. Flexsteel
Industries, Inc., Civil Action No. 3:22–
cv–00893 [Docket No. 2].
The proposed Consent Decree
resolves the alleged liability of Flexsteel
Industries, Inc. (‘‘Flexsteel’’) at the Lane
Street Ground Water Contamination
Superfund Site in Elkhart, Indiana (the
‘‘Site’’) under the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERCLA), 42 U.S.C. 9606, 9607, and
9613, and Ind. Code §§ 13–25–4–9, 13–
25–4–10, and 13–25–4–8, asserted in the
Complaint, for payment by Flexsteel of
$9.8 million. In return, the United States
and State of Indiana agree not to sue
Flexsteel under sections 106 and 107 of
CERCLA or Ind. Code §§ 13–25–4–8
through IC 13–25–4–10 with respect to
the Site.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States and State of
Indiana v. Flexsteel Industries, Inc, D.J.
Ref. No. 90–11–3–11767. All comments
must be submitted no later than thirty
(30) days after the publication date of
this notice. Comments may be
submitted either by email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 87, Number 209 (Monday, October 31, 2022)]
[Notices]
[Pages 65609-65610]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23613]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1108]
Importer of Controlled Substances Application: Mylan
Technologies, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Mylan Technologies, Inc. has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 30, 2022. Such persons may also file a written request for a
hearing on the application on or before November 30, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on October 4, 2022, Mylan Technologies, Inc., 110 Lake
Street, Saint Albans, Vermont 05478-2266, applied to be registered as
an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Methylphenidate........................ 1724 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
finished dosage form (FDF) from foreign sources for analytical testing
and clinical trials in which the foreign FDF will be compared to the
company's own domestically manufactured FDF. This analysis is required
to allow the company to export domestically manufactured FDF to foreign
markets. No other activity for this drug code is authorized for this
registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2).
[[Page 65610]]
Authorization will not extend to the import of Food and Drug
Administration-approved or non-approved finished dosage forms for
commercial sale.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-23613 Filed 10-28-22; 8:45 am]
BILLING CODE P
